Results 281 to 290 of about 318,819 (293)

Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics

Journal of Infectious Diseases, 2020
Sibei Chen, Lingbo Nong, Linling Cheng   +2 more
exaly  

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Nature, 2018
Martin Darvas, Marco L Davila, Gregory J Riggins   +2 more
exaly  

Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease

Expert Opinion on Investigational Drugs, 2020
Zeyun Zhou, Christina Price
exaly  

<p>Targeting the A₃ adenosine receptor to treat cytokine release syndrome in cancer immunotherapy</p>

Drug Design, Development and Therapy, 2019
Shira Cohen, Pnina Fishman
exaly  

Subcutaneous tocilizumab treatment in patients with severe COVID-19–related cytokine release syndrome: An observational cohort study

EClinicalMedicine, 2020
Antonio Mastroianni, Sonia Greco, Valeria Vangeli   +2 more
exaly  

M029 CYTOKINE RELEASE SYNDROME SECONDARY TO BENRALIZUMAB

Annals of Allergy, Asthma & Immunology, 2020
E. Vasquez, I. Carrillo-Martin, S. Chiarella, A. Gonzalez-Estrada   +3 more
openaire   +1 more source

Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19

Respiratory Medicine, 2020
W Larry Glück, Julie C Martin, Anna V Blenda   +2 more
exaly  

Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells

Cancer Letters, 2014
Yongmin Tang
exaly  

Advances in the prediction of cytokine release syndrome

Toxicology Letters, 2014
openaire   +1 more source

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome

OncoImmunology, 2016
Sachiko Okamoto, Naohiro Seo, Junichi Mineno   +2 more
exaly